A lthough some health conditions are spoken about with more nuance and understanding than in the past, inflammatory bowel ...

Visakhapatnam: The Vizag Gut Club Association in collaboration with the Colitis and Crohn’s Foundation India (CCF India) is ...

BOSTON, MA / / October 3, 2024 /PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, ...

GET MORE AI-GENERATED SIGNALS: September 30, 2024, 20:34 pm ET, BY Bill- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...

A retrospective study of a mandatory nonmedical switch in Canada found no significant differences in rates of treatment persistence, loss of response, or adverse events in patients with inflammatory ...

Reddit stock is pushing past a cup-with-handle buy point as the social media player's third-quarter earnings report date ...

Spyre Therapeutics, Inc. interim data from the phase 1 study, using SPY001 in healthy volunteers, is expected by the end of ...

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

Opioid use is more prevalent among individuals with vs without IBD, although not related to a psychiatric comorbidity.

Researchers sought to determine the prevalence, characteristics, management, and outcomes of difficult-to-treat IBD.

The mortality rate in IBD, ranging from 1999 to 2020, remained stable until 2018 when rates began to increase until 2020.